{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:05:24Z","timestamp":1782335124529,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.radonc.2005.11.002","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T07:15:04Z","timestamp":1132730104000},"page":"146-151","source":"Crossref","is-referenced-by-count":11,"title":["Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: A prospective phase II study"],"prefix":"10.1016","volume":"78","author":[{"given":"Paula","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Valavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Aitasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Kulmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Elomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Sillanm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Minn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reidar","family":"Gr\u00e9nman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2005.11.002_bib1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.11.002_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0360-3016(02)03819-1","article-title":"Late toxicity results of the Gortec 94-01 randomized trial comparing radiotherapy with concomitant radiotherapy for advanced-stage oropharynx carcinoma: comparison of LENT\/SOMA, RTOG\/EORTC, and NCI-CTC scoring systems","volume":"55","author":"Denis","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2005.11.002_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0360-3016(02)03792-6","article-title":"Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy\u2014a multicenter randomized trial","volume":"55","author":"Olmi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2005.11.002_bib7","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2005.11.002_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(91)90670-Y","article-title":"Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma","volume":"21","author":"Pinto","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(00)00139-0","article-title":"Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer\u2014report on 3-year tumour control and normal tissue toxicity","volume":"55","author":"Skladowski","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0360-3016(88)90390-2","article-title":"Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes","volume":"14","author":"Wang","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib16","series-title":"TNM classification of malignant tumours","author":"International Union Againt Cancer","year":"1997"},{"key":"10.1016\/j.radonc.2005.11.002_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00016489709124135","article-title":"Microvascular free tissue transfers after preoperative irradiation in head and neck reconstructions","volume":"529","author":"Aitasalo","year":"1997","journal-title":"Acta Otolaryngol (Suppl)"},{"key":"10.1016\/j.radonc.2005.11.002_bib19","first-page":"313","article-title":"The success rate of free flaps after preoperative irradiation in head and neck reconstruction","volume":"86","author":"Aitasalo","year":"1997","journal-title":"Ann Chir Gynaecol"},{"key":"10.1016\/j.radonc.2005.11.002_bib20","first-page":"56","article-title":"The success rate of free flaps after preoperative radiotherapy in head and neck cancer","volume":"30","author":"Aitasalo","year":"2002","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.radonc.2005.11.002_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(01)00347-4","article-title":"A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans Tasmanian Radiation Oncology Group study","volume":"60","author":"Poulsen","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1097-0215(20000420)90:2<80::AID-IJC4>3.0.CO;2-J","article-title":"Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer","volume":"90","author":"Leborgne","year":"2000","journal-title":"Int J Cancer (Radiat Oncol Invest)"},{"key":"10.1016\/j.radonc.2005.11.002_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(97)01944-0","article-title":"A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer","volume":"43","author":"Jackson","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0360-3016(03)01576-1","article-title":"Toxic cure: hyperfractionationated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community","volume":"58","author":"Maguire","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0360-3016(01)01544-9","article-title":"Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy\u2014results of a multicentric randomized German trial in advanced head-and-neck cancer","volume":"50","author":"Staar","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2005.11.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(01)00494-7","article-title":"A multicentre randomized\/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time","volume":"62","author":"Hliniak","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2005.07.010","volume":"23","author":"Budach","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2005.11.002_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hed.1081","article-title":"Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis","volume":"23","author":"Browman","year":"2001","journal-title":"Head Neck"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814005004950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814005004950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T15:55:27Z","timestamp":1547999727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814005004950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0167814005004950"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2005.11.002","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}